Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Last Name

Contact Us
If you have any questions or feedback please contact us.

Maria Odette Gore

TitleAffiliate - DHHA
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus

    Collapse Biography 
    Collapse education and training
    University of Texas Southwestern Medical Center, Dallas, TXCardiovascular Disease Fellowship06/2014
    University of Texas Southwestern Medical Center, Dallas, TXMaster of Science in Clinical Science06/2013
    University of Texas Southwestern Medical Center, Dallas, TXInternal Medicine Residency06/2010
    Collapse awards and honors
    2016K23 Career Development Award, NHLBI / NIH
    2013Women in Cardiology Trainee Award for Excellence, American Heart Association
    2011Travel Award, ACC.11 Scientific Session (San Francisco, CA), American College of Cardiology Texas Chapter

    Collapse Overview 
    Collapse overview
    Dr. Odette Gore is Assistant Professor of Medicine at the University of Colorado and a Cardiologist at Denver Health Medical Center. Dr. Gore's main research interests are in preventive cardiology and cardiovascular biomarkers, and her current research is supported by a Career Development Award (K23) from the National Heart, Lung, and Blood Institute (NHLBI). She is board certified in Internal Medicine, Cardiovascular Disease, Nuclear Cardiology and Adult Comprehensive Echocardiography.

    Collapse Research 
    Collapse research activities and funding
    T32-HL007360     (Joseph A. Hill, MD)Jul 2, 2010 - Jun 30, 2012
    Sponsor: National Heart, Lung, and Blood Institute
    Title: Training in Cardiovascular Research, UT Southwestern Medical Center
    Role: Fellow, Cardiovascular Disease

    UL1-TR001105     (Robert D. Toto, MD)Jul 1, 2011 - Jun 30, 2013
    Sponsor: National Center for Advancing Translational Sciences
    Title: UT Southwestern Center for Translational Medicine
    Role: Trainee, Master of Science in Clinical Science Program

    K23-HL131939     (Maria Odette Gore, MD, MSCS)Jun 8, 2017 - May 31, 2021
    Sponsor: National Heart, Lung, and Blood Institute
    Title: Cardiovascular Disease Prevention in the Community: The Role of Risk Factor Screening and Targeted Health Intervention in Blood Donors
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Gore M, Lana SE, Bishop GA. Colorado State University, Pet Hospice Program. Vet Clin North Am Small Anim Pract. 2019 Mar 04. PMID: 30846381.
      View in: PubMed
    2. Gore MO, Krantz MJ, Albright K, Beaty B, Coronel-Mockler S, Bull S, Estacio RO. A controlled trial of mobile short message service among participants in a rural cardiovascular disease prevention program. Prev Med Rep. 2019 Mar; 13:126-131. PMID: 30568871.
      View in: PubMed
    3. Lew J, Sanghavi M, Ayers CR, McGuire DK, Omland T, Atzler D, Gore MO, Neeland I, Berry JD, Khera A, Rohatgi A, de Lemos JA. Sex-Based Differences in Cardiometabolic Biomarkers. Circulation. 2017 02 07; 135(6):544-555. PMID: 28153991.
      View in: PubMed
    4. Gore MO, McGuire DK. A Test in Context: Hemoglobin A1c and Cardiovascular Disease. J Am Coll Cardiol. 2016 Dec 06; 68(22):2479-2486. PMID: 27908354.
      View in: PubMed
    5. Gore MO, de Lemos JA. Cardiac Troponins and the Future of Precision Medicine. Circ Cardiovasc Interv. 2016 06; 9(6). PMID: 27296203.
      View in: PubMed
    6. Salahuddin UI, Pandey A, Ayers CR, See R, Neeland IJ, Gore MO, Grinsfelder DB, Abdullah SM, Khera A, de Lemos JA, McGuire DK. Effect of treatment with rosiglitazone on high-sensitivity cardiac troponin levels among patients with type 2 diabetes mellitus. Diab Vasc Dis Res. 2016 Mar; 13(2):113-8. PMID: 26701964.
      View in: PubMed
    7. Gore MO, McGuire DK, Lingvay I, Rosenstock J. Predicting cardiovascular risk in type 2 diabetes: the heterogeneity challenges. Curr Cardiol Rep. 2015 Jul; 17(7):607. PMID: 26031671.
      View in: PubMed
    8. Gore MO, Eason SJ, Ayers CR, Turer AT, Khera A, de Lemos JA, McGuire DK, Sayers M. High prevalence of elevated haemoglobin A1C among adolescent blood donors: Results from a voluntary screening programme including 31,546 adolescents. Diab Vasc Dis Res. 2015 Jul; 12(4):272-8. PMID: 25972340.
      View in: PubMed
    9. Atzler D, Gore MO, Ayers CR, Choe CU, Böger RH, de Lemos JA, McGuire DK, Schwedhelm E. Homoarginine and cardiovascular outcome in the population-based Dallas Heart Study. Arterioscler Thromb Vasc Biol. 2014 Nov; 34(11):2501-7. PMID: 25189571.
      View in: PubMed
    10. Sénéchal M, Ayers CR, Szczepaniak LS, Gore MO, See R, Abdullah SM, Berry JD, McGuire DK, McGavock JM. Is cardiorespiratory fitness a determinant of cardiomyopathy in the setting of type 2 diabetes? Diab Vasc Dis Res. 2014 Sep; 11(5):343-51. PMID: 25027700.
      View in: PubMed
    11. Arnold SV, Spertus JA, Lipska KJ, Lanfear DE, Tang F, Grodzinsky A, McGuire DK, Gore MO, Goyal A, Maddox TM, Kosiborod M. Type of ß-blocker use among patients with versus without diabetes after myocardial infarction. Am Heart J. 2014 Sep; 168(3):273-279.e1. PMID: 25173537; PMCID: PMC4151261.
    12. Gore MO, Seliger SL, Defilippi CR, Nambi V, Christenson RH, Hashim IA, Hoogeveen RC, Ayers CR, Sun W, McGuire DK, Ballantyne CM, de Lemos JA. Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay. J Am Coll Cardiol. 2014 Apr 15; 63(14):1441-8. PMID: 24530665; PMCID: PMC3984900.
    13. Gore MO, Eason SJ, Ayers CR, Turer A, Khera A, de Lemos JA, McGuire DK, Sayers M. Glycated hemoglobin in 14,850 adolescent blood donors: a pilot screening program. Diabetes Care. 2014; 37(1):e3-4. PMID: 24356607; PMCID: PMC3867990.
    14. Xing FY, Neeland IJ, Gore MO, Ayers CR, Paixao AR, Turer AT, Berry JD, Khera A, de Lemos JA, McGuire DK. Association of prediabetes by fasting glucose and/or haemoglobin A1c levels with subclinical atherosclerosis and impaired renal function: observations from the Dallas Heart Study. Diab Vasc Dis Res. 2014 Jan; 11(1):11-8. PMID: 24344119.
      View in: PubMed
    15. McGuire DK, Gore MO. Insulin resistance and risk for incident heart failure. JACC Heart Fail. 2013 Dec; 1(6):537-9. PMID: 24622006.
      View in: PubMed
    16. Narang N, Thibodeau JT, Levine BD, Gore MO, Ayers CR, Lange RA, Cigarroa JE, Turer AT, de Lemos JA, McGuire DK. Inaccuracy of estimated resting oxygen uptake in the clinical setting. Circulation. 2014 Jan 14; 129(2):203-10. PMID: 24077170.
      View in: PubMed
    17. Gore MO, Lüneburg N, Schwedhelm E, Ayers CR, Anderssohn M, Khera A, Atzler D, de Lemos JA, Grant PJ, McGuire DK, Böger RH. Symmetrical dimethylarginine predicts mortality in the general population: observations from the Dallas heart study. Arterioscler Thromb Vasc Biol. 2013 Nov; 33(11):2682-8. PMID: 24008162.
      View in: PubMed
    18. Gada E, Owens AW, Gore MO, See R, Abdullah SM, Ayers CR, Rohatgi A, Khera A, de Lemos JA, McGuire DK. Discordant effects of rosiglitazone on novel inflammatory biomarkers. Am Heart J. 2013 Apr; 165(4):609-14. PMID: 23537979.
      View in: PubMed
    19. Gore MO, Patel MJ, Kosiborod M, Parsons LS, Khera A, de Lemos JA, Rogers WJ, Peterson ED, Canto JC, McGuire DK. Diabetes mellitus and trends in hospital survival after myocardial infarction, 1994 to 2006: data from the national registry of myocardial infarction. Circ Cardiovasc Qual Outcomes. 2012 Nov; 5(6):791-7. PMID: 23132330.
      View in: PubMed
    20. Gore MO, McGuire DK. Drugs for type 2 diabetes mellitus: the imperative for cardiovascular outcome assessment. Diab Vasc Dis Res. 2012 Apr; 9(2):85-8. PMID: 22496441.
      View in: PubMed
    21. Narang N, Gore MO, Snell PG, Ayers CR, Lorenzo S, Carrick-Ranson G, Babb TG, Levine BD, Khera A, de Lemos JA, McGuire DK. Accuracy of estimating resting oxygen uptake and implications for hemodynamic assessment. Am J Cardiol. 2012 Feb 15; 109(4):594-8. PMID: 22100029.
      View in: PubMed
    22. McGavock J, Szczepaniak LS, Ayers CR, Abdullah SM, See R, Gore MO, Drazner MH, de Lemos JA, McGuire DK. The effects of rosiglitazone on myocardial triglyceride content in patients with type 2 diabetes: a randomised, placebo-controlled trial. Diab Vasc Dis Res. 2012 Apr; 9(2):131-7. PMID: 22067724.
      View in: PubMed
    23. Hamilton MP, Gore MO, Ayers CR, McGuire DK, Scherer PE. Adiponectin and cardiovascular risk profile in patients with type 2 diabetes mellitus: parameters associated with adiponectin complex distribution. Diab Vasc Dis Res. 2011 Jul; 8(3):190-4. PMID: 21555334.
      View in: PubMed
    24. Gore MO, McGuire DK. Resolving drug effects from class effects among drugs for type 2 diabetes mellitus: more support for cardiovascular outcome assessments. Eur Heart J. 2011 Aug; 32(15):1832-4. PMID: 21471136.
      View in: PubMed
    25. Narang N, Armstead SI, Stream A, Abdullah SM, See R, Snell PG, McGavock J, Ayers CR, Gore MO, Khera A, de Lemos JA, McGuire DK. Assessment of cardiac structure and function in patients without and with peripheral oedema during rosiglitazone treatment. Diab Vasc Dis Res. 2011 Apr; 8(2):101-8. PMID: 21562061.
      View in: PubMed
    26. Gore MO, Masoudi FA, McGuire DK. Diabetes mellitus in patients with myocardial infarction complicated by heart failure: a 'low ejection fraction' equivalent? Eur J Heart Fail. 2010 Nov; 12(11):1156-8. PMID: 20965878.
      View in: PubMed
    27. McGuire DK, Gore MO, Masoudi FA. Diabetes and heart failure in patients with coronary disease: separating markers from mediators. Diabetes Care. 2010 Sep; 33(9):2120-2. PMID: 20805283; PMCID: PMC2928376.
    28. Gore MO, McGuire DK. Cardiovascular disease and type 2 diabetes mellitus: regulating glucose and regulating drugs. Curr Cardiol Rep. 2009 Jul; 11(4):258-63. PMID: 19563725.
      View in: PubMed
    29. Gore MO, McGuire DK. The 10-year post-trial follow-up of the United Kingdom Prospective Diabetes Study (UKPDS): cardiovascular observations in context. Diab Vasc Dis Res. 2009 Jan; 6(1):53-5. PMID: 19156632.
      View in: PubMed
    30. Gore MO, Welch BJ, Geng W, Kabbani W, Maalouf NM, Zerwekh JE, Moe OW, Sakhaee K. Renal phosphate wasting due to tumor-induced osteomalacia: a frequently delayed diagnosis. Kidney Int. 2009 Aug; 76(3):342-7. PMID: 18668025; PMCID: PMC2878273.
    31. Lang T, Barker R, Steinlechner B, Gustorff B, Puskas T, Gore O, Kober A. TENS relieves acute posttraumatic hip pain during emergency transport. J Trauma. 2007 Jan; 62(1):184-8; discussion 188. PMID: 17215752.
      View in: PubMed
    32. Bertalanffy A, Kober A, Bertalanffy P, Gustorff B, Gore O, Adel S, Hoerauf K. Transcutaneous electrical nerve stimulation reduces acute low back pain during emergency transport. Acad Emerg Med. 2005 Jul; 12(7):607-11. PMID: 15995091.
      View in: PubMed
    33. Hülsmann M, Berger R, Mörtl D, Gore O, Meyer B, Pacher R. Incidence of normal values of natriuretic peptides in patients with chronic heart failure and impact on survival: a direct comparison of N-terminal atrial natriuretic peptide, N-terminal brain natriuretic peptide and brain natriuretic peptide. Eur J Heart Fail. 2005 Jun; 7(4):552-6. PMID: 15921794.
      View in: PubMed
    Gore's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    Co-Authors Expand Description
    Similar People Expand Description
    Same Department Expand Description
    Physical Neighbors Expand Description

    Copyright © 2017 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.10.0)